Opening bell ceremony at NASDAQ with participants from NASDAQ-TASE Biomed Investors Conference.
VP Business Development of BioLineRx, Nir Gamliel, is fourth on the right.
BioLineRx participated in Investor Conference in New York for Israeli Biomed companies co-sponsored by NASDAQ and TASE
BioLineRx participated in Investor Conference in New York for Israeli Biomed companies co-sponsored by NASDAQ and TASE
December 6, 2010
Opening bell ceremony at NASDAQ with participants from NASDAQ-TASE Biomed Investors Conference.
VP Business Development of BioLineRx, Nir Gamliel, is fourth on the right.